2012-10-10 09:32:31 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Azaya Therapeutics Incorporated - Product Pipeline Review - 2012" provides data on the Azaya Therapeutics Incorporated's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Azaya Therapeutics Incorporated's corporate website, SEC filings, investor presentations and featured press releases, both from Azaya Therapeutics Incorporated and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Azaya Therapeutics Incorporated - Brief Azaya Therapeutics Incorporated overview including business description, key information and facts, and its locations and subsidiaries.
*

Review of current pipeline of Azaya Therapeutics Incorporated human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Azaya Therapeutics Incorporated with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Azaya Therapeutics Incorporated's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468675_azaya_therapeutics_incorporated_produ ..


Reasons to buy

* Evaluate Azaya Therapeutics Incorporated's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Azaya Therapeutics Incorporated in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Azaya Therapeutics Incorporated's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Azaya Therapeutics Incorporated.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Azaya Therapeutics Incorporated and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Azaya Therapeutics Incorporated Snapshot
Azaya Therapeutics Incorporated Overview
Key Information
Key Facts
Azaya Therapeutics Incorporated - Research and Development Overview
Key Therapeutic Areas
Azaya Therapeutics Incorporated - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Azaya Therapeutics Incorporated - Pipeline Products Glance
Azaya Therapeutics Incorporated Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Azaya Therapeutics Incorporated - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Azaya Therapeutics Incorporated - Drug Profiles
ATI-0721
Product Description
Mechanism of Action
R&D Progress
ATI-1150
Product Description
Mechanism of Action
R&D Progress
docetaxel
Product Description
Mechanism of Action
R&D Progress
Doxorubicin
Product Description
Mechanism of Action
R&D Progress
Azaya Therapeutics Incorporated - Pipeline Analysis
Azaya Therapeutics Incorporated - Pipeline Products by Therapeutic Class
Azaya Therapeutics Incorporated - Pipeline Products by Route of Administration
Azaya Therapeutics Incorporated - Pipeline Products By Mechanism of Action
Azaya Therapeutics Incorporated - Recent Pipeline Updates
Azaya Therapeutics Incorporated - Dormant Projects
Azaya Therapeutics Incorporated - Locations And Subsidiaries
Head Office
Azaya Therapeutics Incorporated, Recent Developments
Azaya Therapeutics Incorporated- Press Release
Jun 13, 2012: Azaya Therapeutics Reports Phase I Clinical Trial Results Of ATI-1123
Dec 10, 2009: Azaya Therapeutics Announces Food and Drug Administration (FDA) Approval Of ATI-1123 For The Treatment Of Solid Tumors
Financial Deals Landscape
Azaya Therapeutics Incorporated, Deals Summary
Azaya Therapeutics Incorporated, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Azaya Therapeutics Secures $1 Million In Venture Financing
Licensing Agreements
Azaya Therapeutics Enters Into Licensing Agreement With The University of Texas Health Science Center at San Antonio
Debt Offering
Azaya Therapeutics Completes Private Placement Of 5% Convertible Notes Due 2012 For $3.5 Million
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Azaya Therapeutics Incorporated, Key Information
Azaya Therapeutics Incorporated, Key Facts
Azaya Therapeutics Incorporated - Pipeline by Indication, 2012
Azaya Therapeutics Incorporated - Pipeline by Stage of Development, 2012
Azaya Therapeutics Incorporated - Monotherapy Products in Pipeline, 2012
Azaya Therapeutics Incorporated - Phase I, 2012
Azaya Therapeutics Incorporated - Pre-Clinical, 2012
Azaya Therapeutics Incorporated - Discovery, 2012
Azaya Therapeutics Incorporated - Pipeline By Therapeutic Class, 2012
Azaya Therapeutics Incorporated - Pipeline By Route of Administration, 2012
Azaya Therapeutics Incorporated - Pipeline Products By Mechanism of Action, 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468675&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.